Seres Therapeutics (MCRB) vs MIRA Pharmaceuticals (MIRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
MIRA Pharmaceuticals is the larger company by market cap ($31.3 million vs $27.2 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MCRB | MIRA |
|---|---|---|
| Share price | $2.71 | $0.7455 |
| Market cap | $27.22M | $31.33M |
| 1-day change | +3.04% | +6.05% |
| YTD return | — | -50.63% |
| 1-year return | — | -44.37% |
| EPS (TTM) | $-2.42 | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $29.98 | $2.45 |
| 52-week low | $2.42 | $0.60 |
| Distance from 52-week high | -90.96% | -69.57% |
| Analyst consensus | none | none |
| Avg. price target upside | +527.31% | +369.48% |
| Average volume | 72.26K | 585.04K |
| Shares outstanding | 10.04M | 42.02M |
| Employees | 66 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Seres Therapeutics
MCRB stock →Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhance GI epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation.
Health Care · Biotechnology: Pharmaceutical Preparations · 66 employees
About MIRA Pharmaceuticals
MIRA stock →MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.
Health Care · Biotechnology: Pharmaceutical Preparations
MCRB vs MIRA FAQ
Which is bigger, Seres Therapeutics or MIRA Pharmaceuticals?
MIRA Pharmaceuticals (MIRA) is larger, with a market capitalization of $31.33M compared with $27.22M for Seres Therapeutics (MCRB).
Are Seres Therapeutics and MIRA Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.